Growth Metrics

Omnicell (OMCL) Liabilities and Shareholders Equity (2016 - 2025)

Omnicell (OMCL) has disclosed Liabilities and Shareholders Equity for 16 consecutive years, with $1.9 billion as the latest value for Q3 2025.

  • On a quarterly basis, Liabilities and Shareholders Equity changed N/A to $1.9 billion in Q3 2025 year-over-year; TTM through Dec 2025 was $6.2 billion, a 41.79% increase, with the full-year FY2024 number at $2.1 billion, down 4.76% from a year prior.
  • Liabilities and Shareholders Equity was $1.9 billion for Q3 2025 at Omnicell, down from $2.1 billion in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $2.3 billion in Q1 2024 to a low of $1.9 billion in Q1 2021.
  • A 5-year average of $2.1 billion and a median of $2.2 billion in 2025 define the central range for Liabilities and Shareholders Equity.
  • Peak YoY movement for Liabilities and Shareholders Equity: soared 53.18% in 2021, then dropped 5.79% in 2025.
  • Omnicell's Liabilities and Shareholders Equity stood at $2.1 billion in 2021, then grew by 3.19% to $2.2 billion in 2022, then grew by 0.73% to $2.2 billion in 2023, then fell by 4.76% to $2.1 billion in 2024, then decreased by 8.13% to $1.9 billion in 2025.
  • Per Business Quant, the three most recent readings for OMCL's Liabilities and Shareholders Equity are $1.9 billion (Q3 2025), $2.1 billion (Q2 2025), and $2.2 billion (Q1 2025).